4//SEC Filing
Raptor Pharmaceutical Corp 4
Accession 0001140361-16-051878
CIK 0001070698operating
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 7:45 PM ET
Size
14.3 KB
Accession
0001140361-16-051878
Insider Transaction Report
Form 4
Happel David
Chief Commerical Officer
Transactions
- Award
Common Stock
2016-02-09+25,017→ 30,246 total - Award
Stock options (right to buy)
2016-02-09+93,784→ 93,784 totalExercise: $3.74Exp: 2026-02-09→ Common Stock (93,784 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs"). The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU, subject to continued service.
- [F2]One-fourth of the total RSUs vest annually, beginning on the first anniversary of the grant date.
- [F3]The options have a four year vesting schedule, vesting 1/48th per month following the grant date.
Documents
Issuer
Raptor Pharmaceutical Corp
CIK 0001070698
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070698
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 7:45 PM ET
- Size
- 14.3 KB